Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Sunday, February 23, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices
admin
-
February 10, 2025
Latest Pharma-News
Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium
admin
-
February 3, 2025
Latest Pharma-News
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
admin
-
February 3, 2025
Latest Pharma-News
Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG
admin
-
January 24, 2025
Latest Pharma-News
Bayer and Pula Foundation partner up to insure 10 million smallholder farmers in Sub-Saharan Africa and South Asia
admin
-
January 24, 2025
Latest Pharma-News
Officials:Blackberries sold in Fresh Thyme grocery stores cause hepatitis A
admin
-
November 21, 2019
1
Latest Pharma-News
NGFA–KSU Food Safety Modernization Act Feed Industry Training course to set regulations for safe animal feed
admin
-
November 21, 2019
0
Latest Pharma-News
USFDA Approved GIVLAARI(givosiran) for the Treatment of Adults with Acute Hepatic Porphyria
admin
-
November 21, 2019
0
Latest Pharma-News
Merck’s anti-PD-1 therapy KEYTRUDA(pembrolizumab) for Metastatic or Unresectable Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC)
admin
-
November 21, 2019
0
Latest Pharma-News
Due to Potential Battery Failure Getinge’s Maquet / Datascope Recalls Cardiosave Hybrid, Cardiosave Rescue, CS300 and CS100/100i Intra-Aortic Balloon Pumps (IABP)
admin
-
November 21, 2019
0
Latest Pharma-News
First-in-human clinical trial to evaluate CAR-Treg Cell Therapy TX200 for Kidney Transplantation approved for Phase 1/2 Clinical Trial
admin
-
November 21, 2019
0
Latest Pharma-News
KarXT enrolled in Phase II clinical trial for the treatment of acute psychosis in schizophrenia patients
admin
-
November 20, 2019
0
Latest Pharma-News
TWILIGHT trial showed that Brilinta (ticagrelor) monotherapy reduced the risk of clinically relevant bleeding compared to dual antiplatelet therapy (DAPT) in patients with non-ST...
admin
-
November 20, 2019
0
Latest Pharma-News
Novartis Phase III PARAGON-HF study: Substantial reductions in heart failure with preserved ejection fraction with Entresto
admin
-
November 19, 2019
0
Latest Pharma-News
Cardiff University’s scientist awarded the funding of £373k to diagnose pancreatic cancer at an earlier stage
admin
-
November 19, 2019
0
Latest Pharma-News
SurVaxM: A novel anti-cancer immunotherapy for the treatment of glioblastoma brain cancers
admin
-
November 19, 2019
0
Latest Pharma-News
Initiation Of First Large-Scale Registry :To Evaluate Real-World Lipid Management And The Effectiveness Of PCSK9 Inhibitors
admin
-
November 18, 2019
0
1
...
143
144
145
Page 144 of 145
- Advertisment -
Most Read
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices
February 10, 2025
Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium
February 3, 2025
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
February 3, 2025
Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG
January 24, 2025